|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_on1152526572 |
| 003 |
OCoLC |
| 005 |
20231120010449.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
200429s2020 ne o 001 0 eng d |
| 040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d EBLCP
|d OCLCF
|d UKMGB
|d N$T
|d UKAHL
|d OCLCQ
|d OCLCO
|d K6U
|d OCLCQ
|d OCLCO
|
| 015 |
|
|
|a GBC055858
|2 bnb
|
| 016 |
7 |
|
|a 019786940
|2 Uk
|
| 020 |
|
|
|a 0081028296
|
| 020 |
|
|
|a 9780081028292
|q (electronic bk.)
|
| 020 |
|
|
|z 9780081028285
|q (print)
|
| 035 |
|
|
|a (OCoLC)1152526572
|
| 050 |
|
4 |
|a QD549
|
| 082 |
0 |
4 |
|a 541/.345
|2 23
|
| 245 |
0 |
0 |
|a Colloids for nanobiotechnology :
|b synthesis, characterization and potential applications /
|c edited by Wolfgang J. Parak, Neus Feliu.
|
| 264 |
|
1 |
|a Amsterdam. Netherlands :
|b Elsevier,
|c 2020.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Frontiers of nanoscience ;
|v volume 16
|
| 500 |
|
|
|a Includes index.
|
| 505 |
0 |
|
|a Intro -- Colloids for Nanobiotechnology: Synthesis, Characterization and Potential Applications -- Copyright -- Contents -- Contributors -- Chapter 1: Colloids for nanobiotechnology: An introduction -- Chapter 2: Surface-enhanced Raman scattering (SERS) sensing of nucleic acids -- 2.1. Introduction -- 2.2. Indirect SERS detection of nucleic acids -- 2.3. Direct SERS detection of nucleic acids -- 2.4. Conclusions -- Acknowledgments -- References -- Chapter 3: Energy transfer with nanoparticles for in vitro diagnostics -- 3.1. Introduction -- 3.2. Semiconductor QDs
|
| 505 |
8 |
|
|a 3.2.1. QDs as FRET donors for IVD -- 3.2.1.1. Enzyme sensing -- 3.2.1.2. Nucleic acid sensing -- 3.2.1.3. Immunoassays -- 3.2.2. QDs as FRET acceptors for IVD -- 3.2.2.1. Luminescence lanthanide complex as FRET donor -- 3.2.2.1.1. Nucleic acid sensing -- 3.2.2.1.2. Antibody/antigen sensing -- 3.2.2.2. UCNPs as FRET donors -- 3.2.3. QDs as FRET donors and acceptors -- 3.2.3.1. Small molecule sensing -- 3.2.3.2. Antibody/antigen sensing -- 3.3. Upconversion nanoparticles -- 3.3.1. FRET for biosensing with UCNPs -- 3.3.2. UCNPs as energy donors for IVD -- 3.3.2.1. Small molecule sensing
|
| 505 |
8 |
|
|a 3.3.2.2. Nucleic acid sensing -- 3.3.2.3. Antibody/antigen sensing -- 3.4. Gold nanoparticles -- 3.4.1. AuNPs as energy acceptors for IVD -- 3.4.1.1. Nucleic acid sensing -- 3.4.1.2. Protein sensing -- 3.4.1.3. Small molecule sensing -- 3.5. Carbon quantum dots -- 3.5.1. Optical properties of CQDs -- 3.5.2. CQDs as ET donors for IVD -- 3.5.2.1. Organic dyes as ET acceptors -- 3.5.2.2. Metal nanoclusters as ET acceptors -- 3.5.2.3. QDs as ET acceptors -- 3.5.2.4. Other nanomaterials as ET acceptors/quenchers -- 3.6. Perspectives -- References -- Chapter 4: Nanoparticles for imaging application
|
| 505 |
8 |
|
|a 4.1. Introduction -- 4.2. Imaging modalities -- 4.3. Nanoparticles for imaging applications -- 4.3.1. Optical imaging -- 4.3.2. Ultrasound imaging -- 4.3.3. Photoacoustic imaging -- 4.3.4. Computed tomography -- 4.3.5. Magnetic resonance imaging -- 4.3.6. Magnetic particle imaging -- 4.3.7. Positron emission tomography and single photon emission computed tomography -- 4.3.8. Multimodal imaging -- 4.4. Perspective -- References -- Chapter 5: Colloidal nanoparticles as pharmaceutical agents -- 5.1. Introduction -- 5.1.1. Nano-pharmacokinetics (Nano-PK) -- 5.1.2. Nano-pharmacodynamics (Nano-PD)
|
| 505 |
8 |
|
|a 5.1.3. Multifunctional efficiency -- 5.2. Autonomous TNPs -- 5.2.1. Drug-containing TNPs -- 5.2.2. Nanoparticles with intrinsic mechanisms for the induction of cell death -- 5.2.2.1. Reactive oxygen species-generating TNPs -- 5.2.2.2. Ferroptosis induction -- 5.2.2.3. Ion overdose -- 5.2.2.4. Autophagy induction -- 5.2.2.5. Therapy besides cancer -- 5.2.2.6. Detoxifying TNPs -- 5.3. Exogenous energy-converting TNPs -- 5.3.1. Thermal therapy -- 5.3.2. Photodynamic therapy -- 5.3.3. Sonodynamic therapy -- 5.3.4. Radiotherapy -- 5.4. Immunotherapeutic nanoparticles
|
| 650 |
|
0 |
|a Colloids.
|
| 650 |
|
0 |
|a Nanobiotechnology.
|
| 650 |
|
6 |
|a Nanobiotechnologie.
|0 (CaQQLa)000286131
|
| 650 |
|
7 |
|a Colloids
|2 fast
|0 (OCoLC)fst00868334
|
| 650 |
|
7 |
|a Nanobiotechnology
|2 fast
|0 (OCoLC)fst01894713
|
| 700 |
1 |
|
|a Parak, Wolfgang J.,
|e editor.
|
| 700 |
1 |
|
|a Feliu, Neus,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|z 9780081028285
|
| 830 |
|
0 |
|a Frontiers of nanoscience ;
|v v. 16.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/18762778/16
|z Texto completo
|
